The Breast DCIS Score test
traditional assessment methods
The Breast DCIS Score report includes information that goes beyond standard clinical pathologic factors, such as1-3:
- An individualized prediction of the 10-year risk of any local recurrence (DCIS or invasive carcinoma) or an invasive local recurrence
- An established baseline for consideration of absolute benefit from radiation therapy (XRT)
- Quantitative ER and PR single gene expression values
Genomic testing
genetic testing
Genetic tests help people understand their risk for getting cancer. Genomic tests help people who have been diagnosed with cancer plan their care. The Breast DCIS Score test examines 12 cancer-related genes in a patient’s tumor. The activity of these genes influences the behavior of the tumor, including how likely it is to grow and spread. The Breast DCIS Score test looks at these genes to help you and your patient make decisions about appropriate care.
Breast DCIS Score test
Breast Recurrence Score® test
The Breast DCIS Score test is specifically for patients with ductal carcinoma in situ (DCIS) treated by local excision. The Oncotype DX Breast Recurrence Score® test is a similar test for patients with early-stage and ER-positive invasive breast cancer.
-
References
